Stockholders’ Equity (Details Narrative) - USD ($)						6 Months Ended		9 Months Ended	12 Months Ended	18 Months Ended
	Sep. 16, 2024	Jun. 13, 2024	Jan. 04, 2024	Oct. 31, 2023	Apr. 10, 2023	Jun. 30, 2024	Jun. 30, 2023	Sep. 30, 2024	Dec. 31, 2023	Nov. 05, 2024	Jul. 10, 2023	May 11, 2023	May 10, 2023	Dec. 31, 2022
Stockholders' equity, reverse stock split			1 for 20
Common stock, shares issued								7,066,772	7,066,772
Common stock, shares outstanding								7,066,772	7,066,772
Share based compensation expense						$ 0
Share based compensation forfeited							5,333
Common stock, shares authorized								200,000,000	200,000,000
Common stock, par value								$ 0.02	$ 0.02
Preferred stock, shares authorized								47,000	47,000
Preferred stock, par value								$ 0.02	$ 0.02
Stockholders' Equity Note, Stock Split				reverse stock split of 1 for 55
Preferred stock, shares issued								0	0
Preferred stock, shares outstanding								0	0
Number of shares owned											4
Other Expenses		$ 5,758,000
Common Stock [Member] | DSS BioHealth Securities, Inc. [Member] | Maximum [Member]
Ownership percentage				88.00%
Common Stock [Member] | DSS BioHealth Securities, Inc. [Member] | Minimum [Member]
Ownership percentage				12.00%
Impact Bio Medical Inc [Member]
Common stock, shares issued								11,503,955	10,000,000			0
Common stock, shares outstanding								11,503,955	10,000,000			0
Common stock, shares authorized												3,877,282,251	4,000,000,000
Common stock, par value													$ 0.001
Common stock, voting										Each share of Common Stock when issued, shall have one (1) vote on all matters presented to the stockholders.
Preferred stock, shares authorized													100,000,000
Preferred stock, par value													$ 0.001
Preferred stock, shares issued						60,496,041			60,496,041
Preferred stock, shares outstanding						60,496,041			60,496,041
Number of shares owned											1
Impact Bio Medical Inc [Member] | Prior To Split [Member]
Common stock, shares issued												0
Common stock, shares outstanding												0
Common stock, shares authorized												125,073,621
DSS BioHealth Securities, Inc. [Member] | Common Stock [Member]
Common stock, shares authorized				60,496,041
Impact BioMedical, Inc. [Member]
Stockholders' equity, reverse stock split				reverse stock split of 1 for 55
Common stock, shares outstanding														3,877,282,251
Equity reserve stock split								70,496,041
Impact BioMedical, Inc. [Member] | IPO [Member]
Number of shares issued	1,500,000
Common stock, shares issued								11,497,703
Common stock, shares outstanding								11,497,703
Common stock, par value	$ 0.001
Share Price	$ 3.00
Other Expenses								$ 3,726,000
Costs and Expenses								$ 1,500,000
Stock descrption								A final prospectus relating to this Offering was filed with the Commission on September 16, 2024. The shares of Common Stock were approved to list on the NYSE American under the symbol “IBO” and began trading there on September 16, 2024. The Company also issued warrants to the Representative and its affiliates (the “Representative’s Warrants”) warrants to purchase the number of shares of Common Stock in the aggregate equal to 5% of the Common Stock to be issued and sold in this offering (including any Shares of Common Stock sold upon exercise of the over-allotment option, if applicable). The Representative’s Warrants are exercisable for a price per share equal to 125% of the public offering price. The warrants are exercisable at any time, in whole or in part, commencing nine (9) months from the date of commencement of sales of the offering and ending on the third anniversary thereof.
Sale of Stock, Number of Shares Issued in Transaction								1,500,000
Sale of stock number of shares issued in remaining								9,997,703
Impact BioMedical, Inc. [Member] | Common Stock [Member]
Equity reserve stock split								60,496,041
Convertible Common Stock [Member]
Common stock, shares issued									140,264,240
Common stock, shares outstanding									140,264,240
Equity reserve stock split									7,066,772
Series A Convertible Preferred Stock [Member] | DSS BioHealth Securities, Inc. [Member]
Common stock, shares authorized				60,496,041
Series A Convertible Preferred Stock [Member] | Impact BioMedical, Inc. [Member]
Equity reserve stock split				60,496,041
Frank Heuszel [Member] | Employment Agreement [Member]
Number of shares issued					1,247,078
Number of shares of common stock, values					$ 268,000